Australia's largest stock trading and investment forum Australia's #1 stock forum

K2P

Click for more information

0.00%

18.0¢ kore potash limited

diluting the company by 25% @ 19 cents per share protects the...

First 7 Last

Share
Profile

Follow
ddzx

28,706 Posts.

237

27/10/15

15:07

Post #: 16263734
Share

Originally posted by PabloP ↑

I see this as a prudent move by the board on several fronts.

As mentioned by cheapprice it offers protection from Dingyi who have been trying to get this company on the cheap (I can't blame them for trying, the market is very tough at the moment and being opportunistic can pay off ten fold).

Secondly, given the share price (whether it is being manipulated or not is not, we will never know), it covers the potential funding gap from the options not being exercised.

The above factors may force Dingyi, if they are serious, to offer a decent value proposition to the shareholders of this company. There is so much upside with the projects currently in their portfolio and their relatively low CAPEX and OPEX (to be confirmed) but on face value it appears that the projects will be very competitive.

I believe the positives far outweigh the argument of further dilution to existing shareholders and makes life difficult for opportunistic low ball bids.

It will be interesting to see what unfolds in the coming months...... will it become binding, will Dingyi come back, is there another party watching from afar.......

All IMHO. GLTA

Expand

diluting the company by 25% @ 19 cents per share protects the company from cheap takeover?

K2P Price at posting: 18.5¢ Sentiment: None Disclosure: Not Held
Upvote

0 Great analysis

Reply

Top Stories

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Chaos reigns markets – so let's take stock of where we're at ahead of December

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

ACW

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

There are more pages in this discussion • 3 more messages in this thread...

First 7 Last

Add K2P (ASX) to my watchlist